Peter A. Netland, MD, PhD appointed Chair of the Department of Ophthalmology at Eastern Virginia Medical School (EVMS) in Norfolk, VA
Aniridia North America (ANA) is pleased to announce that our Board Chair, Dr. Peter Netland, is moving to Eastern Virginia Medical School (EVMS) in Norfolk, Virginia as Professor and Chair of the Department of Ophthalmology.
2023 In Review & 2024 Strategic Plan
Thank you to all who supported and donated to ANA in 2023. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2024.
The infographics below provide a snapshot of the accomplishments in 2023 and highlight some goals set for 2024.
Focal Point – Episode 3 – Aniridia 101: How to Care for a Child’s Eyes with Aniridia
ANA’s 3rd episode of Focal Point –Aniridia 101: How to Care for a Child’s Eyes with Aniridia– was held on August 22 with Guest: Dr. Alex Levin. View a recording here.
ANA to Host Biennial Scientific Symposium Dedicated to PAX6 and Aniridia
Charlottesville, VA – Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2023 Aniridia North America Symposium: PAX6,…
“Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond”
ANA is pleased to announce that the article “Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond” has been published in July 2023 issue of The…
ANA Launches Patient and Family Advisory Board
ANA is pleased to announce the creation of a Patient and Family Advisory Board. The purpose of the ANA Patient and Family Advisory Board (PFAB) is to provide persons with aniridia…
“Visual Acuity in Aniridia and WAGR Syndrome”
An article was recently published in the journal Clinical Ophthalmology regarding a new study comparing the visual acuity in aniridia vs. WAGR syndrome. Here is a plain language summary of…
ANA Joins Global Genes & Formalizes Partnerships
ANA recognizes that, in the rare disease community, we are stronger when working together with those who share common goals. Recently, ANA acted upon this vision by joining Global Genes and formalizing partnerships with VFT and the IWSA.
ANA Completes First Year as Non-profit Organization
2022 was Aniridia North America’s first calendar year after receiving its 501(c)(3) determination from the IRS. Recently, the Board of Directors met for their annual in-person meeting to reflect on the accomplishments of the last year, and to develop a strategic plan for 2023.
ANA Participation in the 6th European Aniridia Conference
Part of ANA’s vision is to coordinate and synergize its activities and efforts with Aniridia Europe and other international organizations to provide more effective support and affiliations for the global aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited and to participate in the 6th European Aniridia Conference, which was hosted by the Asociación Española de Aniridia in San Juan de Alicante, Spain in June of 2022.
